Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Cost-Effectiveness Analysis of Delayed-Release Dimethyl Fumarate for The Treatment of Relapsing Remitting Multiple Sclerosis In Spain.
Microsatellite polymorphism in haem oxygenase 1 gene promoter in multiple sclerosis.
Assessing possible selection bias in a national voluntary MS longitudinal study in Australia.
The Retrovirus/Superantigen Hypothesis of Multiple Sclerosis.
Epstein Barr virus infection reactivation as a possible trigger of primary biliary cirrhosis-like syndrome in a patient with multiple sclerosis in the course of fingolimod treatment.
[The role of regulatory T cells in the development of autoimmune process in multiple sclerosis].
Brain stem and cerebellar atrophy in chronic progressive neuro-Behçet's disease.
Facilitation of Corticospinal Connections in Able-bodied People and People With Central Nervous System Disorders Using Eight Interventions.
Long-term management of natalizumab discontinuation in a large monocentric cohort of multiple sclerosis patients.
Molecular analysis of interleukin-25 exons 1 and 2 and its serum levels in Iranian patients with multiple sclerosis.
Neuroradiological evaluation of demyelinating disease.
Kynurenines in the CNS: recent advances and new questions.
Future treatment approaches to multiple sclerosis.
Neurons and T cells: Understanding this interaction for inflammatory neurological diseases.
Contingent negative variation is associated with cognitive dysfunction and secondary progressive disease course in multiple sclerosis.
The feasibility of collecting information from people with Multiple Sclerosis for the UK MS Register via a web portal: characterising a cohort of people with MS.
Heterogeneity of oligodendrocyte progenitor cells in adult human brain.
Lipocalin-2 is increased in progressive multiple sclerosis and inhibits remyelination.
Missing links in multiple sclerosis etiology. A working connecting hypothesis.
Heligmosmoides polygyrus: EAE remission is correlated with different systemic cytokine profiles provoked by L4 and adult nematodes.
[Treatment of nausea and vomiting with prokinetics and neuroleptics in palliative care patients : A review.]
Exacerbation of experimental autoimmune encephalomyelitis in ceramide synthase 6 knockout mice is associated with enhanced activation/migration of neutrophils.
[Neurodegeneration in multiple sclerosis and the neuroprotective effect of glatiramer acetate: a literature review].
Intractable hiccup caused by spinal cord lesions in demyelination disease.
Coenzyme Q10 supplementation ameliorates inflammatory markers in patients with multiple sclerosis: a double blind, placebo, controlled randomized clinical trial.
Pages
« first
‹ previous
…
284
285
286
287
288
289
290
291
292
…
next ›
last »